Cullinan Oncology Inc — Cash Flow (NASDAQ:CGEM) | MetaTrader

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Cash from operating activities 43.43 M126.66 M134.28 M145.3 M 174.27 M Cash from investing activities 333.77 M248.97 M35.81 M136.31 M 141.63 M Cash from financing activities 268.78 M25.93 M40.75 M266.19 M 1.96 M Free cash flow 43.43 M125.53 M134.07 M145.3 M 174.27 M

Новости

Cullinan Therapeutics: Thesis Strengthening For T-Cell Engager Specialist (NASDAQ:CGEM)

Cullinan Therapeutics, Inc. (CGEM) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript

TheStreet Pro Analysts Say, “Big Tech Names are Anything But Cheap – Buy These 2 Stocks Instead” - TipRanks.com

古根海姆给Cullinan Oncology股票首次评级为"买入"，目标价30美元

Guggenheim initiates Cullinan Oncology stock with Buy rating, $30 target

Cullinan Therapeutics Stock: Cash-Rich Biotech With Multiple Value Drivers (NASDAQ:CGEM)

Are Medical Stocks Lagging AIM ImmunoTech (AIM) This Year?

Here's What Could Help Cullinan Therapeutics (CGEM) Maintain Its Recent Price Strength

Cullinan Therapeutics计划发布关键自身免疫项目数据

Cullinan Therapeutics plans data readouts for key autoimmune programs

Cowen重申Cullinan Oncology股票在ASH数据后的买入评级

Cowen reiterates Buy rating on Cullinan Oncology stock after ASH data